Reevaluating Bevacizumab: The Role of VEGF Inhibitors in Metastatic Breast Cancer
Pamela Hallquist Viale, RN, MS, CS, ANP, AOCNP®
The author has no potential conflicts to disclose.
J Adv Pract Oncol 2011;2:138-139 |
DOI: 10.6004/jadpro.2011.2.3.1 |
© 2011 Harborside Press®
For access to the full length article, please sign in